PE20060661A1 - Composicion que comprende liposomas para el tratamiento de escleorosis multiple - Google Patents
Composicion que comprende liposomas para el tratamiento de escleorosis multipleInfo
- Publication number
- PE20060661A1 PE20060661A1 PE2005001065A PE2005001065A PE20060661A1 PE 20060661 A1 PE20060661 A1 PE 20060661A1 PE 2005001065 A PE2005001065 A PE 2005001065A PE 2005001065 A PE2005001065 A PE 2005001065A PE 20060661 A1 PE20060661 A1 PE 20060661A1
- Authority
- PE
- Peru
- Prior art keywords
- treatment
- scleorosis
- composition including
- including liposomes
- bodies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
REFERIDA A UNA COMPOSICION QUE COMPRENDE PEQUENAS DOSIS DE CUERPOS QUE LLEVAN PG TAL COMO LIPOSOMAS, LOS CUALES TIENEN HASTA UN GRADO DE AL MENOS UN 10% EN PESO DE FOSFATIDILGLICEROL, DE PREFERENCIA DE ENTRE 50% Y 100%, Y TIENEN UN DIAMETRO ENTRE 20 NANOMETROS Y 500 MICROMETROS. DICHOS CUERPOS PRESENTAN GRUPOS PRINCIPALES DE GLICEROL FOSFATO SOBRE SUS SUPERFICIES EXTERNAS Y SON UTILES PARA EL TRATAMIENTO DE LA ESCLEROSIS MULTIPLE
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20040613 | 2004-09-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060661A1 true PE20060661A1 (es) | 2006-09-16 |
Family
ID=35207670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001065A PE20060661A1 (es) | 2004-09-15 | 2005-09-14 | Composicion que comprende liposomas para el tratamiento de escleorosis multiple |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060105032A1 (es) |
| EP (1) | EP1793833A1 (es) |
| AR (1) | AR052642A1 (es) |
| CA (1) | CA2578248A1 (es) |
| EA (1) | EA200700626A1 (es) |
| PE (1) | PE20060661A1 (es) |
| TW (1) | TW200616645A (es) |
| UY (1) | UY29119A1 (es) |
| WO (1) | WO2006029886A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563022B2 (en) * | 2006-10-11 | 2013-10-22 | Board Of Regents Of The University Of Texas System | Particles for cell targeting |
| WO2008121811A2 (en) | 2007-03-29 | 2008-10-09 | National Jewish Medical And Research Center | Surfactant lipids, compositions thereof, and uses thereof |
| US8173115B2 (en) * | 2008-07-29 | 2012-05-08 | The Board Of Regents Of The University Of Texas System | Particle compositions with a pre-selected cell internalization mode |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0114713A (pt) * | 2000-10-16 | 2004-01-13 | Neopharm Inc | Formulação lipossÈmica de mitoxantrona |
| CA2427467C (en) * | 2000-11-09 | 2010-01-12 | Neopharm, Inc. | Sn-38 lipid complexes and methods of use |
| CA2368656A1 (en) * | 2002-01-21 | 2003-07-21 | Vasogen Ireland Limited | Receptor-ligand pairing for anti-inflammatory response |
-
2005
- 2005-09-14 EP EP05784528A patent/EP1793833A1/en not_active Withdrawn
- 2005-09-14 WO PCT/EP2005/009994 patent/WO2006029886A1/en active Application Filing
- 2005-09-14 AR ARP050103849A patent/AR052642A1/es unknown
- 2005-09-14 EA EA200700626A patent/EA200700626A1/ru unknown
- 2005-09-14 US US11/227,984 patent/US20060105032A1/en not_active Abandoned
- 2005-09-14 CA CA002578248A patent/CA2578248A1/en not_active Abandoned
- 2005-09-14 PE PE2005001065A patent/PE20060661A1/es not_active Application Discontinuation
- 2005-09-15 UY UY29119A patent/UY29119A1/es unknown
- 2005-09-15 TW TW094131868A patent/TW200616645A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006029886A1 (en) | 2006-03-23 |
| AR052642A1 (es) | 2007-03-28 |
| EP1793833A1 (en) | 2007-06-13 |
| UY29119A1 (es) | 2006-05-31 |
| EA200700626A1 (ru) | 2007-10-26 |
| CA2578248A1 (en) | 2006-03-23 |
| US20060105032A1 (en) | 2006-05-18 |
| TW200616645A (en) | 2006-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021014831A2 (es) | Lípidos de amina ionizables y nanopartículas lipídicas | |
| AR113031A1 (es) | Composiciones de nanopartículas lipídicas (lnp) que comprende arn | |
| PA8720801A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento de la depresion | |
| CO2021008838A2 (es) | Lípidos con amina modificados | |
| GT200500275A (es) | Nuevos herbicidas | |
| NI201000085A (es) | Derivados bis - (sulfonilamino) en terapia 066. | |
| CO6290631A2 (es) | Composición oral que contiene amino ácidos y un agente blanqueador | |
| UY27740A1 (es) | Nuevos compuestos | |
| GT200500325A (es) | Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de quinasa | |
| PA8592301A1 (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| UY30314A1 (es) | Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion | |
| PE20120342A1 (es) | Formulacion de anticuerpo | |
| PE20080999A1 (es) | Azolilmetiloxiranos, su uso para combatir hongos fitopatogenos, asi como productos que los contienen | |
| UY31546A1 (es) | Derivados bis-(sulfonilamino) en terapia 205 | |
| UY28859A1 (es) | Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento | |
| SV2010003559A (es) | Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrofilos | |
| AR052233A1 (es) | Formulacion liofilizada, estabilizada, para derivados de la cefalosporina | |
| TW200730178A (en) | Aerosol formulations for the inhalation of β-agonists | |
| CL2008003576A1 (es) | Compuestos derivados de amida del acido 6,7-dihidro-5h-imidazo[1,2-alfa]imidazol-3-carboxilico; composicion farmaceutica que los comprende; y usos en el tratamiento de una afeccion inflamatoria. | |
| GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
| CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
| UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
| CL2022001692A1 (es) | Compuestos activos frente a receptores nucleares | |
| UY30363A1 (es) | Derivados sustituidos de la n-(3-oxo-2,3-dihidro-1h-isoindol-4-il)-1-naftamida, procesos de preparacion, composiciones farmacéuticas y aplicaciones | |
| GT200600130A (es) | Tetrahidropiridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |